Literature DB >> 11211751

[A case of ventricular tachycardia immediately after electroconvulsive therapy in a schinzophrenic patient].

K Urabe1, T Koguchi, K Ishikawa, H Sato, M Shinohara, Y Okuda, T Kitajima, T Isao.   

Abstract

A 33 year-old man weighting, 93 kg with schizophrenia underwent repeated electroconvulsive therapy (ECT) under general anesthesia with thiamylal 200 mg and suxamethonium 80 mg. On his fourth ECT, he developed ventricular tachycardia (VT) immediately after the treatment under general anesthesia with the same agents. The duration of VT was approximately 30 s. The VT returned to sinus rhythm without any special treatment. We speculate that light anesthesia with a small amount of thiopental associated with release of serum potassium caused by suxamethonium induced increased release of catecholamine by ECT to cause VT. After that incident, the patient underwent ECT six times under general anesthesia with thiamylal 250 mg and vecuronium 8 mg, in combination with preventive injection of magnesium sulfate 20 g without any cardiovascular complications. We conclude that the anesthetic management of patients undergoing ECT under general anesthesia should be paid a careful attention for cardiovascular instability, even if they do not have any heart diseases.

Entities:  

Mesh:

Year:  2001        PMID: 11211751

Source DB:  PubMed          Journal:  Masui        ISSN: 0021-4892


  3 in total

1.  A case of nonsustained ventricular tachycardia immediately following modified electroconvulsive therapy in a depressive patient.

Authors:  Yukari Koga; Yasunori Mishima; Masahiro Momozaki; Teruyuki Hiraki; Kazuo Ushijima
Journal:  J Anesth       Date:  2011-05-15       Impact factor: 2.078

Review 2.  [Anesthesia outside the core operating area].

Authors:  D Deckert; A Zecha-Stallinger; T Haas; A von Goedecke; W Lederer; V Wenzel
Journal:  Anaesthesist       Date:  2007-10       Impact factor: 1.041

3.  Recurrent ventricular tachycardia during the electroconvulsive therapy procedure: A case report.

Authors:  Sandeep Grover; Shivali Aggarwal
Journal:  Indian J Psychiatry       Date:  2020-03-17       Impact factor: 1.759

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.